Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Drug delivery systems for mitochondrial targeting.

Nanoscale·2025

Same author

Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598.

Journal of controlled release : official journal of the Controlled Release Society·2025

Same author

Inhibition of craniosynostosis and premature suture fusion in <i>Twist1</i> mutant mice with RNA nanoparticle gene therapy.

Science advances·2025

Same author

Advantages and challenges of polymer-lipid hybrid nanoparticles for the delivery of biotech drugs.

Nanomedicine (London, England)·2025

Same author

The reduced-charge melittin analogue MelP5 improves the transfection of non-viral DNA nanoparticles.

Journal of peptide science : an official publication of the European Peptide Society·2022

Same author

Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease.

Journal of controlled release : official journal of the Controlled Release Society·2021

Same journal

A Review on Nanocarrier-Based Strategies for Sunitinib Delivery: Advances in Pharmacokinetic Enhancement and Targeted Theranostics.

AAPS PharmSciTech·2026

Same journal

A Review on Modular Peptide Anchoring Strategies for Functionalizing Liposomal Nanocarriers: Advancing Non-covalent Design Toward Targeted Cancer Therapy.

AAPS PharmSciTech·2026

Same journal

Vegetable Butter-Based Nanocarriers: Do Nanoparticulation and Quercetin Loading Modulate In vitro Cellular Effects Involved in Wound Healing?

AAPS PharmSciTech·2026

Same journal

Hot-Melt Extrusion of Bupropion with Three Ethylcellulose Grades for Pellet Feedstock Preparation and Screw-Based 3D Printing of Sustained-Release Tablets.

AAPS PharmSciTech·2026

Same journal

Enhanced Stability and Transdermal Delivery of Semaglutide Using an L-Arginine Based Dissolving Microneedle System.

AAPS PharmSciTech·2026

Same journal

The Preparation and Physicochemical Characterization of a Triple Synergistic Nanoplatform Designed for Targeted Subcutaneous Delivery of Sitagliptin with Potential for β-Cell Preservation.

AAPS PharmSciTech·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 28, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Nanoparticle ligand presentation for targeting solid tumors.

Jason T Duskey¹, Kevin G Rice

¹Division of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Iowa, Iowa City, Iowa, 52242, USA.

AAPS Pharmscitech

|June 15, 2014

Summary

This summary is machine-generated.

Ligand-targeted nanoparticles show promise for cancer treatment, but challenges remain in optimizing delivery to tumors and avoiding the liver. Future success depends on precise control over nanoparticle properties and ligand presentation.

More Related Videos

Biofunctionalization of Magnetic Nanomaterials

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

Related Experiment Videos

Last Updated: Apr 28, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Biofunctionalization of Magnetic Nanomaterials

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

Area of Science:

Nanoscience and Nanotechnology
Biomedical Engineering
Oncology

Background:

Ligand-targeted nanoparticles are a promising strategy for cancer therapy.
Current research focuses on overcoming challenges in nanoparticle design and delivery for solid tumors.

Purpose of the Study:

To review ligands used for targeting nanoparticles to solid tumors.
To highlight hurdles in nanoparticle development for clinical cancer treatment.

Main Methods:

Review of scientific literature on ligand-targeted nanoparticles for cancer.
Analysis of challenges in nanoparticle biodistribution, ligand loading, and cellular uptake.

Main Results:

Significant hurdles exist in translating nanoparticle technology from lab to clinic.
Optimizing nanoparticle stealth and targeting is crucial for effective tumor delivery.
Controlling ligand density on nanoparticles (e.g., on polyethylene glycol) remains a challenge.

Conclusions:

Precise control over nanoparticle size, shape, charge, and ligand presentation is essential for successful cancer therapy.
Advances in nanoparticle stealth and targeting are needed to improve efficacy and minimize off-target effects.